G. Lefebvre

Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.

R. Gesser, M. van Cleeff, G. de Bruyn, 2016, Vaccine.

Nafarelin for endometriosis: A large‐scale, danazol‐controlled trial of efficacy and safety, with 1‐year follow‐up

C. Nilsson, D. Barlow, P. Devroey, 1992, Fertility and sterility.

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Jennifer G. Robinson, Alex A. Knopman, D. Rujescu, 2021, The Lancet Neurology.

A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout

Robert L. Martin, C. Mcwherter, Heather L Williams, 2016, Arthritis & rheumatology.

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

A. Borobia, H. Schuitemaker, Andrew Gibson, 2022, The Lancet Infectious Diseases.

Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease

Keith A. Johnson, William J. Shankle, M. Mintun, 2021, JAMA neurology.